Key facts
- This page summarizes Jesse Shefferman's Form 4 filing for Protara Therapeutics, Inc. (TARA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 22 Jan 2026, 16:30.
Jesse Shefferman - 20 Jan 2026 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)
- Reporting relationship
- CEO and President, Director
- Issuer ticker
- TARA
- Reported as of
- 20 Jan 2026
- Net transaction value
- -$91,403
- SEC form
- 4
- Accepted by SEC
- 22 Jan 2026, 16:30:26 UTC
- Prior SEC filing
- 21 Jan 2026
- Next SEC filing
- 27 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jesse Shefferman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jesse Shefferman filed Form 4 for Protara Therapeutics, Inc. (TARA) on 22 Jan 2026.
Change
- Previous filing in this sequence was filed on 21 Jan 2026.
- Current net transaction value: -$91,403.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001799167
Primary reporting owner
Shefferman Jesse
- Relationship
- CEO and President, Director
- Address
- C/O PROTARA THERAPEUTICS, INC., 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK
- Signature
- /s/ Jesse Shefferman
- Signature date
- 22 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TARA
transaction
Common Stock
Tax liability
- Transaction value
- $91,403
- Shares
- -16,322
- Change %
- -1.6%
- Price
- $5.60
- Shares after
- 1,030,564
- Date
- 20 Jan 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on January 19, 2023 and January 19, 2024.